Newer markers for hepatocellular carcinoma

This publication has 31 references indexed in Scilit:

• Des–Gamma Carboxyprothrombin Can Differentiate Hepatocellular Carcinoma From Nonmalignant Chronic Liver Disease in American Patients
  Hepatology, 2003
• Serum insulin‐like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus‐related cirrhosis
  Cancer, 2002
• Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C‐viral chronic liver diseases
  Cancer, 2002
• Trends in biomarker research for cancer detection
  The Lancet Oncology, 2001
• Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
  Journal of Hepatology, 2001
• Utility of lentil lectin affinity of α-fetoprotein in the diagnosis of hepatocellular carcinoma
  Journal of Hepatology, 1996
• A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients
  Hepatology, 1995
• The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-gamma-carboxy prothrombin
  Liver Transplantation and Surgery, 1995
• Statistical design and monitoring of the carotene and retinol efficacy trial (CARET)
  Controlled Clinical Trials, 1993
• Measurement of Immunoreactive Prothrombin Precursor and Vitamin-K-Dependent Gamma-Carboxylation in Human Hepatocellular Carcinoma Tissues: Decreased Carboxylation of Prothrombin Precursor as a Cause of Des-Gamma-Carboxyprothrombin Synthesis
  Tumor Biology, 1990